News

Eli Lilly and Company (LLY) Diabetes Medication Successful in Children and Adolescents

Eli Lilly and Co. (NYSE: LLY) is one of the best beginner stocks to buy, according to analysts. On September 17, the company ...
WVTF

Eli Lilly announces manufacturing plant near Richmond

The Goochland County plant will employ about 650 people when it's fully operational, according to an announcement from the ...

Eli Lilly and Company to invest in $5 billion facility in Goochland, Youngkin announces

Eli Lilly and Company will invest $5 billion in a manufacturing facility in Goochland County, according to an announcement by Governor Glenn Youngkin on Tuesday.

Novo Nordisk Stock Jumps. New Ozempic Data for Seniors Beats Rival Eli Lilly Medicine.

Novo Nordisk published another set of data on its popular diabetes and weight-loss treatment and, this time, investors ...

Eli Lilly and Company: Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with ...

PEDS, Mounjaro met the primary and all key secondary endpoints at 30 weeks and showed sustained improvement in glycemic control and continued BMI reduction ...

Eli Lilly pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial

Eli Lilly said orforglipron was better at lowering blood sugar levels than Novo Nordisk's oral semaglutide, and helped ...

Data on Eli Lilly’s Weight Loss Pill Hasn’t Thrilled Investors. New Updates Are Complicating the Picture.

The drugmaker Eli Lilly’s reign as the undisputed king of the weight loss trade came under threat in early August, after ...

Eli Lilly gets a boost from new pill data; execs say US fast track not a sure thing

Eli Lilly's bid for approval for an experimental weight-loss pill got a boost on Wednesday with new clinical trial data, but ...